Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28.9M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
7.9M
-
Shares change
-
+1.74M
-
Total reported value, excl. options
-
$106M
-
Value change
-
+$23.5M
-
Number of buys
-
37
-
Number of sells
-
-32
-
Price
-
$13.46
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2023
86 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q4 2023.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.9M shares
of 28.9M outstanding shares and own 27.37% of the company stock.
Largest 10 shareholders include Saba Capital Management, L.P. (1.42M shares), Cornerstone Advisors, LLC (494K shares), 1607 Capital Partners, LLC (480K shares), Allspring Global Investments Holdings, LLC (454K shares), MORGAN STANLEY (430K shares), AQR Arbitrage LLC (384K shares), CLOUGH CAPITAL PARTNERS L P (375K shares), RPO LLC (339K shares), NEEDHAM INVESTMENT MANAGEMENT LLC (314K shares), and FLAGSHIP HARBOR ADVISORS, LLC (264K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.